跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,753 条关于
“lutetium Lu 177 vipovotide tetraxetan”
全部
2,753
临床试验
1,364
药物
922
机构
14
资讯
453
去年
PSMA-Targeted Therapies Transform Prostate Cancer Treatment Landscape
去年
Lutetium Lu 177 Vipivotide Tetraxetan Shows Promise in Prostate Cancer Treatment
3年前
FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
去年
Lutetium Lu 177 Dotatate Shows Promise in Metastatic Bronchopulmonary Neuroendocrine Tumors
9个月前
Lutetium Lu 177 Dotatate Demonstrates Significant Efficacy in Advanced Intracranial Meningioma Phase 2 Trial
3年前
Nanopharmaceutics Completes Enrollment in Phase 2 Neuroendocrine Tumor Study Combining Triapine with Lutetium Lu 177 Dotatate
去年
CellBion's Lu-177-DGUL Shows Promise in Metastatic Prostate Cancer Treatment
3个月前
Delaware Court Clears Path for Curium's Lutetium Lu 177 Dotatate in GEP-NETs, Invalidating Novartis Patents
去年
Telix's Illuccix Receives Expanded Approval in Australia and Canada for PSMA-Targeted Therapy Selection
去年
Blue Earth Therapeutics Secures $76.5M to Advance PSMA-Targeted Radioligand Therapies
第 1 页，共 46 页
上一页
下一页
